Northwest Biotherapeutics Provides Update On Final Preparations For Marketing Authorization Application

/PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor...

Related Keywords

United States ,America ,Les Goldman ,Dave Innes ,University Of Pennsylvania ,Exchange Commission ,Company Dcvax ,Company Securities ,Healthcare Products Regulatory Agency ,Marketing Authorization Application ,North America ,Private Securities Litigation Reform Act ,Risk Factors ,Northwest Biotherapeutics ,Health Care Amp Hospitals ,Otc ,Mallcap ,Medical Pharmaceuticals ,Biotechnology ,Pharmaceuticals ,